M3 Wake Research, Inc. ( Site 0014) — Raleigh, North Carolina

M3 Wake Research, Inc. ( Site 0014) is a clinical research site located in Raleigh, North Carolina, United States 27612.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

M3 Wake Research, Inc. ( Site 0014) has participated in 1 clinical trials.

Therapeutic areas: Papillomavirus Infections, Coronavirus Disease (COVID-19).

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for M3 Wake Research, Inc. ( Site 0014)?

M3 Wake Research, Inc. ( Site 0014) has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has M3 Wake Research, Inc. ( Site 0014) conducted?

M3 Wake Research, Inc. ( Site 0014) has 1 clinical trials on record. Their work covers Papillomavirus Infections, Coronavirus Disease (COVID-19).

Is M3 Wake Research, Inc. ( Site 0014) accredited by Crixeo Health?

M3 Wake Research, Inc. ( Site 0014) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about M3 Wake Research, Inc. ( Site 0014)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.